Table of Content

1. Preface

1.1. Market Definition and Scope

1.2. Market Segmentation

1.3. Key Research Objectives

1.4. Research Highlights


2. Assumptions and Research Methodology


3. Executive Summary : Global Cough Hypersensitivity Syndrome Treatment Market


4. Market Overview

4.1. Introduction

4.1.1. Respiratory Drug Classes Definition

4.1.2. Industry Evolution/Developments

4.2. Overview

4.3. Market Dynamics

4.3.1. Drivers

4.3.2. Restraints

4.3.3. Opportunities

4.4. Global Cough Hypersensitivity Syndrome Treatment Market Value (US$ Mn) and Forecast, 2017–2027

4.4.1. Market Revenue Projections (US$ Mn)

4.5. Porter’s Five Force Analysis


5. Key Insights

5.1. Epidemiology Cough hypersensitivity syndrome

5.2. Pipeline Analysis


6. Global Cough Hypersensitivity Syndrome Treatment Market Value (US$ Mn) Forecast, by Drug Class

6.1. Introduction & Definition

6.2. Key Findings / Developments

6.3. Global Cough Hypersensitivity Syndrome Treatment Market Value (US$ Mn) Forecast, By Drug Class, 2017–2027

6.3.1. Antitussive Agents

6.3.2. Inhaled Corticosteroids (ICS)

6.3.3. Short Acting Beta2-Agonists (SABA)

6.3.4. Anti-cholinergics

6.3.5. Antihistamines

6.3.6. Proton Pump Inhibitors

6.3.7. Others

6.4. Global Cough Hypersensitivity Syndrome Treatment Market Attractiveness Analysis, by Drug Class


7. Global Cough Hypersensitivity Syndrome Treatment Market Value (US$ Mn) Forecast, By Distribution Channel

7.1. Introduction & Definition

7.2. Key Findings / Developments

7.3. Global Cough Hypersensitivity Syndrome Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

7.3.1. Hospital Pharmacies

7.3.2. Retail Pharmacies

7.3.3. Online Pharmacies

7.4. Global Cough Hypersensitivity Syndrome Treatment Market Attractiveness Analysis, by Distribution Channel


8. Global Cough Hypersensitivity Syndrome Treatment Market Value (US$ Mn) Forecast, By Region

8.1. Key Findings

8.2. Global Cough Hypersensitivity Syndrome Treatment Market Value (US$ Mn) Forecast, by Region, 2017–2027

8.2.1. North America

8.2.2. Europe

8.2.3. Asia Pacific

8.2.4. Latin America

8.2.5. Middle East & Africa

8.3. Global Cough Hypersensitivity Syndrome Treatment Market Attractiveness Analysis, by Region


9. North America Cough Hypersensitivity Syndrome Treatment Market Value Analysis and Forecast

9.1. Introduction

9.1.1. Key Findings

9.2. North America Cough Hypersensitivity Syndrome Treatment Market Value (US$ Mn) Forecast By Drug Class, 2017–2027

9.2.1. Antitussive Agents

9.2.2. Inhaled Corticosteroids (ICS)

9.2.3. Short Acting Beta2-Agonists (SABA)

9.2.4. Anti-cholinergics

9.2.5. Antihistamines

9.2.6. Proton Pump Inhibitors

9.2.7. Others

9.3. North America Cough Hypersensitivity Syndrome Treatment Market Value (US$ Mn) Forecast By Distribution Channel, 2017–2027

9.3.1. Hospital Pharmacies

9.3.2. Retail Pharmacies

9.3.3. Online Pharmacies

9.4. North America Cough Hypersensitivity Syndrome Treatment Market Value (US$ Mn) Forecast By Country, 2017–2027

9.4.1. U.S.

9.4.2. Canada

9.5. North America Cough Hypersensitivity Syndrome Treatment Market Attractiveness Analysis

9.5.1. By Drug Class

9.5.2. By Distribution Channel

9.5.3. By Country


10. Europe Cough Hypersensitivity Syndrome Treatment Market Analysis and Forecast

10.1. Introduction

10.1.1. Key Findings

10.2. Europe Cough Hypersensitivity Syndrome Treatment Market Value (US$ Mn) Forecast By Drug Class, 2017–2027

10.2.1. Antitussive Agents

10.2.2. Inhaled corticosteroids (ICS)

10.2.3. Short-Acting Beta2-Agonists (SABA)

10.2.4. Anti-cholinergics

10.2.5. Antihistamines

10.2.6. Proton Pump Inhibitors

10.2.7. Others

10.3. Europe Cough Hypersensitivity Syndrome Treatment Market Value (US$ Mn) Forecast By Distribution Channel, 2017–2027

10.3.1. Hospital Pharmacies

10.3.2. Retail Pharmacies

10.3.3. Online Pharmacies

10.4. Europe Cough Hypersensitivity Syndrome Treatment Market Value (US$ Mn) Forecast By Country/Sub-region, 2017–2027

10.4.1. Germany

10.4.2. U.K.

10.4.3. France

10.4.4. Spain

10.4.5. Italy

10.4.6. Rest of Europe

10.5. Europe Cough Hypersensitivity Syndrome Treatment Market Attractiveness Analysis

10.5.1. By Drug Class

10.5.2. By Distribution Channel

10.5.3. By Country


11. Asia Pacific Cough Hypersensitivity Syndrome Treatment Market Analysis and Forecast

11.1. Introduction

11.1.1. Key Findings

11.2. Asia Pacific Cough Hypersensitivity Syndrome Treatment Market Value (US$ Mn) Forecast By Drug Class, 2017–2027

11.2.1. Antitussive Agents

11.2.2. Inhaled corticosteroids (ICS)

11.2.3. Short-Acting Beta2-Agonists (SABA)

11.2.4. Anti-cholinergics

11.2.5. Antihistamines

11.2.6. Proton Pump Inhibitors

11.2.7. Others

11.3. Asia Pacific Cough Hypersensitivity Syndrome Treatment Market Value (US$ Mn) Forecast By Distribution Channel, 2017–2027

11.3.1. Hospital Pharmacies

11.3.2. Retail Pharmacies

11.3.3. Online Pharmacies

11.4. Asia Pacific Cough Hypersensitivity Syndrome Treatment Market Value (US$ Mn) Forecast By Country/Sub-region, 2017–2027

11.4.1. China

11.4.2. Japan

11.4.3. India

11.4.4. Australia & New Zealand

11.4.5. Rest of Asia Pacific

11.5. Asia Pacific Cough Hypersensitivity Syndrome Treatment Market Attractiveness Analysis

11.5.1. By Drug Class

11.5.2. By Distribution Channel

11.5.3. By Country/Sub-region

12. Latin America Cough Hypersensitivity Syndrome Treatment Market Analysis and Forecast

12.1. Introduction

12.1.1. Key Findings

12.2. Latin America Cough Hypersensitivity Syndrome Treatment Market Value (US$ Mn) Forecast By Drug Class, 2017–2027

12.2.1. Antitussive Agents

12.2.2. Inhaled corticosteroids (ICS)

12.2.3. Short-Acting Beta2-Agonists (SABA)

12.2.4. Anti-cholinergics

12.2.5. Antihistamines

12.2.6. Proton Pump Inhibitors

12.2.7. Others

12.3. Latin America Cough Hypersensitivity Syndrome Treatment Market Value (US$ Mn) Forecast By Distribution Channel, 2017–2027

12.3.1. Hospital Pharmacies

12.3.2. Retail Pharmacies

12.3.3. Online Pharmacies

12.4. Latin America Cough Hypersensitivity Syndrome Treatment Market Value (US$ Mn) Forecast By Country/Sub-region, 2017–2027

12.4.1. Brazil

12.4.2. Mexico

12.4.3. Rest of Latin America

12.5. Latin America Cough Hypersensitivity Syndrome Treatment Market Attractiveness Analysis

12.5.1. By Drug Class

12.5.2. By Distribution Channel

12.5.3. By Country/Sub-region

13. Middle East & Africa Cough Hypersensitivity Syndrome Treatment Market Analysis and Forecast

13.1. Introduction

13.1.1. Key Findings

13.2. Middle East & Africa Cough Hypersensitivity Syndrome Treatment Market Value (US$ Mn) Forecast By Drug Class, 2017–2027

13.2.1. Antitussive Agents

13.2.2. Inhaled corticosteroids (ICS)

13.2.3. Short-Acting Beta2-Agonists (SABA)

13.2.4. Anti-cholinergics

13.2.5. Antihistamines

13.2.6. Proton Pump Inhibitors

13.2.7. Others

13.3. Middle East & Africa Cough Hypersensitivity Syndrome Treatment Market Value (US$ Mn) Forecast By Distribution Channel, 2017–2027

13.3.1. Hospital Pharmacies

13.3.2. Retail Pharmacies

13.3.3. Online Pharmacies

13.4. Middle East & Africa Cough Hypersensitivity Syndrome Treatment Market Value (US$ Mn) Forecast By Country/Sub-region, 2017–2027

13.4.1. GCC

13.4.2. South Africa

13.4.3. Rest of Middle East & Africa

13.5. Middle East & Africa Cough Hypersensitivity Syndrome Treatment Market Attractiveness Analysis

13.5.1. By Drug Class

13.5.2. By Distribution Channel

13.5.3. By Country/Sub-region


14. Competition Landscape

14.1. Market Player – Competition Matrix (By Tier and Size of companies)

14.2. Market Share Analysis by Company (2018)

14.3. Company Profiles

14.3.1. Pfizer, Inc.

14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

14.3.1.2. Financial Overview

14.3.1.3. Product Portfolio

14.3.1.4. Strategic Overview

14.3.1.5. SWOT Analysis

14.3.2. GlaxoSmithKline plc

14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

14.3.2.2. Financial Overview

14.3.2.3. Product Portfolio

14.3.2.4. Strategic Overview

14.3.2.5. SWOT Analysis

14.3.3. Boehringer Ingelheim GmbH

14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

14.3.3.2. Financial Overview

14.3.3.3. Product Portfolio

14.3.3.4. Strategic Overview

14.3.3.5. SWOT Analysis

14.3.4. AstraZeneca

14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)

14.3.4.2. Financial Overview

14.3.4.3. Product Portfolio

14.3.4.4. Strategic Overview

14.3.4.5. SWOT Analysis

14.3.5. F. Hoffmann-La Roche Ltd.

14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

14.3.5.2. Financial Overview

14.3.5.3. Product Portfolio

14.3.5.4. Strategic Overview

14.3.5.5. SWOT Analysis

14.3.6. Teva Pharmaceutical Industries Ltd.

14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)

14.3.6.2. Financial Overview

14.3.6.3. Product Portfolio

14.3.6.4. Strategic Overview

14.3.6.5. SWOT Analysis

14.3.7. Novartis AG

14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)

14.3.7.2. Financial Overview

14.3.7.3. Product Portfolio

14.3.7.4. Strategic Overview

14.3.7.5. SWOT Analysis

14.3.8. Merck & Co., Inc. (Merck Sharp & Dohme Corp)

14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)

14.3.8.2. Financial Overview

14.3.8.3. Product Portfolio

14.3.8.4. Strategic Overview

14.3.8.5. SWOT Analysis

14.3.9. Vertex Pharmaceuticals Incorporated

14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)

14.3.9.2. Financial Overview

14.3.9.3. Product Portfolio

14.3.9.4. Strategic Overview

14.3.9.5. SWOT Analysis

14.3.10. Johnson & Johnson Consumer Inc.

14.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)

14.3.10.2. Financial Overview

14.3.10.3. Product Portfolio

14.3.10.4. Strategic Overview

14.3.10.5. SWOT Analysis



List of Figures



Figure 01: Global Cough Hypersensitivity Syndrome Treatment Market Value (US$ Mn) and Distribution (%), by Region, 2019 and 2027

Figure 02: Global Cough Hypersensitivity Syndrome Treatment Market Value (US$ Mn) Forecast, 2017–2027

Figure 03: Global Cough Hypersensitivity Syndrome Treatment Market Value Share (%), by Drug Class (2019)

Figure 04: Global Cough Hypersensitivity Syndrome Treatment Market Value Share (%), by Distribution Channel (2019)

Figure 05: Global Cough Hypersensitivity Syndrome Treatment Market Value Share (%), by Region (2019)

Figure 06: Porter’s Five Force Analysis– Cough Hypersensitivity Syndrome Treatment Market

Figure 07: Epidemiology of Cough Hypersensitivity Syndrome (Chronic Cough)

Figure 08: Global Cough Hypersensitivity Syndrome Treatment Market Value Share Analysis, by Drug Class, 2018 and 2027

Figure 09: Global Cough Hypersensitivity Syndrome Treatment Market Value (US$ Mn) Forecast, by Antitussive Agents, 2017–2027

Figure 10: Global Cough Hypersensitivity Syndrome Treatment Market Value (US$ Mn) Forecast, by Inhaled Corticosteroids, 2017–2027

Figure 11: Global Cough Hypersensitivity Syndrome Treatment Market Value (US$ Mn) Forecast, by Short acting Beta-2 Agonists, 2017–2027

Figure 12: Global Cough Hypersensitivity Syndrome Treatment Market Value (US$ Mn) Forecast, by Anticholinergics, 2017–2027

Figure 13: Global Cough Hypersensitivity Syndrome Treatment Market Value (US$ Mn) Forecast, by Antihistamines, 2017–2027

Figure 14: Global Cough Hypersensitivity Syndrome Treatment Market Value (US$ Mn) Forecast, by Proton Pump Inhibitors, 2017–2027

Figure 15: Global Cough Hypersensitivity Syndrome Treatment Market Value (US$ Mn) Forecast, by Others, 2017–2027

Figure 16: Global Cough Hypersensitivity Syndrome Treatment Market Attractiveness, by Drug Class, 2019?2027

Figure 17: Global Cough Hypersensitivity Syndrome Treatment Market Value Share Analysis, by Distribution Channel, 2018 and 2027

Figure 18: Global Cough Hypersensitivity Syndrome Treatment Market Value (US$ Mn) Forecast, by Hospital Pharmacies, 2017–2027

Figure 19: Global Cough Hypersensitivity Syndrome Treatment Market Value (US$ Mn) Forecast, by Retail Pharmacies, 2017–2027

Figure 20: Global Cough Hypersensitivity Syndrome Treatment Market Value (US$ Mn) Forecast, by Online Pharmacies, 2017–2027

Figure 21: Global Cough Hypersensitivity Syndrome Treatment Market Attractiveness, by Distribution Channel, 2019?2027

Figure 22: Global Cough Hypersensitivity Syndrome Treatment Market: Regional Outlook

Figure 23: Global Cough Hypersensitivity Syndrome Treatment Market Value Share Analysis, by Region, 2018 and 2027

Figure 24: Global Cough Hypersensitivity Syndrome Treatment Market Attractiveness Analysis, by Region, 2019–2027

Figure 25: North America Cough Hypersensitivity Syndrome Treatment market Value (US$ Mn) Forecast, 2019–2027

Figure 26: North America Cough Hypersensitivity Syndrome Treatment market Value Share, by Country, 2018 and 2027

Figure 27: North America Cough Hypersensitivity Syndrome Treatment market Attractiveness, by Country, 2019–2027

Figure 28: North America Cough Hypersensitivity Syndrome Treatment market Value Share Analysis, by Drug Class, 2018 and 2027

Figure 29: North America Cough Hypersensitivity Syndrome Treatment market Attractiveness Analysis, by Drug Class, 2019?2027

Figure 30: North America Cough Hypersensitivity Syndrome Market Value Share Analysis, by Distribution Channel, 2018 and 2027

Figure 31: North America Cough Hypersensitivity Syndrome Treatment market Attractiveness, by Distribution Channel, 2019–2027

Figure 32: Europe Cough Hypersensitivity Syndrome Treatment Market Value (US$ Mn) Forecast, 2019–2027

Figure 33: Europe Cough Hypersensitivity Syndrome Treatment Market Value Share, by Country/Sub-region, 2018 and 2027

Figure 34: Europe Cough Hypersensitivity Syndrome Treatment Market Attractiveness, by Country/Sub-region, 2019–2027

Figure 36: Europe Cough Hypersensitivity Syndrome Treatment Market Attractiveness Analysis, by Drug Class, 2019?2027

Figure 35: Europe Cough Hypersensitivity Syndrome Treatment Market Value Share Analysis, by Drug Class, 2018 and 2027

Figure 37: Europe Cough Hypersensitivity Syndrome Treatment Market Value Share Analysis, by Distribution Channel, 2018 and 2027

Figure 38: Europe Cough Hypersensitivity Syndrome Treatment Market Attractiveness, by Distribution Channel, 2019–2027

Figure 39: Asia Pacific Cough Hypersensitivity Syndrome Treatment Market Value (US$ Mn) Forecast, 2019–2027

Figure 40: Asia Pacific Cough Hypersensitivity Syndrome Treatment Market Value Share, by Country/Sub-region, 2018 and 2027

Figure 41: Asia Pacific Cough Hypersensitivity Syndrome Treatment Market Attractiveness, by Country/Sub-region, 2019–2027

Figure 42: Asia Pacific Cough Hypersensitivity Syndrome Treatment Market Value Share Analysis, by Drug Class, 2018 and 2027

Figure 43: Asia Pacific Cough Hypersensitivity Syndrome Market Attractiveness Analysis, by Drug Class, 2019?2027

Figure 44: Asia Pacific Cough Hypersensitivity Syndrome Treatment Market Value Share Analysis, by Distribution Channel, 2018 and 2027

Figure 45: Asia Pacific Cough Hypersensitivity Syndrome Treatment Market Attractiveness, by Distribution Channel, 2019–2027

Figure 46: Latin America Cough Hypersensitivity Syndrome Treatment Market Value (US$ Mn) Forecast, 2019–2027

Figure 47: Latin America Cough Hypersensitivity Syndrome Treatment Market Value Share, by Country/Sub-region, 2018 and 2027

Figure 48: Latin America Cough Hypersensitivity Syndrome Treatment Market Attractiveness, by Country/Sub-region, 2019–2027

Figure 49: Latin America Cough Hypersensitivity Syndrome Treatment Market Value Share Analysis, by Drug Class, 2018 and 2027

Figure 50: Latin America Cough Hypersensitivity Syndrome Treatment Market Attractiveness Analysis, by Drug Class, 2019?2027

Figure 51: Latin America Cough Hypersensitivity Syndrome Treatment Market Value Share Analysis, by Distribution Channel, 2018 and 2027

Figure 52: Latin America Cough Hypersensitivity Syndrome Treatment Market Attractiveness, by Distribution Channel, 2019–2027

Figure 53: Middle East & Africa Cough Hypersensitivity Syndrome Treatment Market Value (US$ Mn) Forecast, 2019–2027

Figure 54: Middle East & Africa Cough Hypersensitivity Syndrome Treatment Market Value Share, by Country/Sub-region, 2018 and 2027

Figure 55: Middle East & Africa Cough Hypersensitivity Syndrome Treatment Market Attractiveness, by Country/Sub-region, 2019–2027

Figure 56: Middle East & Africa Cough Hypersensitivity Syndrome Market Value Share Analysis, by Drug Class, 2018 and 2027

Figure 57: Middle East & Africa Cough Hypersensitivity Syndrome Market Attractiveness Analysis, by Drug Class, 2019?2027

Figure 58: Middle East & Africa Cough Hypersensitivity Syndrome Treatment Market Value Share Analysis, by Distribution Channel, 2018 and 2027

Figure 59: Middle East & Africa Cough Hypersensitivity Syndrome Treatment Market Attractiveness, by Distribution Channel, 2019–2027

Figure 60: Pfizer, Inc. R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2018

Figure 61: Pfizer, Inc. Breakdown of Net Sales (%), by Region, 2018

Figure 62: Pfizer, Inc. Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018

Figure 63: Pfizer, Inc. Breakdown of Net Sales (%), by Business Segment, 2018

Figure 64: GSK R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2018

Figure 65: GSK Breakdown of Net Sales (%), by Geography, 2018

Figure 66: GSK Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018

Figure 67: GSK Breakdown of Net Sales (%), by Business Segment, 2018

Figure 68: Boehringer Ingelheim GmbH R&D Expenditure (US$ Mn), 2016–2018

Figure 69: Boehringer Ingelheim GmbH Breakdown of Net Sales, by Region (Company Level), 2018

Figure 70: Boehringer Ingelheim GmbH Revenue (US$ Bn) and Y-o-Y Growth (%), 2014–2018

Figure 71: Boehringer Ingelheim GmbH Breakdown of Net Sales, by Business Segment, 2018

Figure 72: AstraZeneca Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018

Figure 73: AstraZeneca Breakdown of Net Sales (%), by Region/Country, 2018

Figure 74: AstraZeneca R&D Expenses (US$ Mn), 2015–2018

Figure 75: AstraZeneca Breakdown of Net Sales (%), by Business Segment, 2018

Figure 76: F. Hoffmann-La Roche Ltd. Revenue (US$ Bn) and Y-o-Y Growth (%), 2015–2018

Figure 77: F. Hoffmann-La Roche Ltd. Breakdown of Net Sales, by Business Segment, 2018

Figure 78: F. Hoffmann-La Roche Ltd. Breakdown of Net Sales, by Region, 2018

Figure 79: F. Hoffmann-La Roche Ltd. Research & Development Cost (US$ Mn), 2015–2017

Figure 80: Teva Pharmaceutical Industries Ltd. Revenue (US$ Mn) & Y-o-Y Growth (%), 2015–2018

Figure 81: Teva Pharmaceutical Industries Ltd. R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2018

Figure 82: Novartis AG Revenue (US$ Bn) and Y-o-Y Growth (%), 2015–2018

Figure 83: Novartis AG Breakdown of Net Sales, by Region, 2018

Figure 84: Novartis AG R&D Intensity and Sales & Marketing Intensity - Company Level, 2017–2018

Figure 85: Novartis AG Breakdown of Net Sales, by Business Segment, 2018

Figure 86: Merck & Co., Inc. Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018

Figure 87: Merck & Co., Inc. Revenue Breakdown of Net Sales (%), by Segment, 2018

Figure 88: Merck & Co., Inc. Breakdown of Net Sales (%), by Region/Country, 2018

Figure 89: Merck & Co., Inc. R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2018

Figure 90: Vertex Pharmaceuticals Incorporated Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018

Figure 91: Vertex Pharmaceuticals Incorporated Breakdown of Net Sales (%), by Region/Country, 2018

Figure 92: Vertex Pharmaceuticals Incorporated R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2018

Figure 93: Johnson & Johnson Consumer Inc. Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018

Figure 94: Johnson & Johnson Consumer Inc. Breakdown of Net Sales (%), by Region, 2018

Figure 95: Johnson & Johnson Consumer Inc. Breakdown of Net Sales (%), by Business Segment, 2018

 

List of Tables



Table 01: Pipeline Analysis

Table 02: Global Cough Hypersensitivity Syndrome Treatment Market Value (US$ Mn) Forecast, by Drug Class, 2017–2027

Table 03: Global Cough Hypersensitivity Syndrome Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

Table 04: Global Cough Hypersensitivity Syndrome Treatment Market Value (US$ Mn) Forecast, by Region, 2017–2027

Table 05: North America Cough Hypersensitivity Syndrome Treatment market Value (US$ Mn) Forecast, by Country, 2017–2027

Table 06: North America Cough Hypersensitivity Syndrome Treatment market Value (US$ Mn) Forecast, by Drug Class, 2017–2027

Table 07: North America Cough Hypersensitivity Syndrome Treatment market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

Table 08: Europe Cough Hypersensitivity Syndrome Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 09: Europe Cough Hypersensitivity Syndrome Treatment Market Value (US$ Mn) Forecast, by Drug Class, 2017–2027

Table 10: Europe Cough Hypersensitivity Syndrome Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

Table 11: Asia Pacific Cough Hypersensitivity Syndrome Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 12: Asia Pacific Cough Hypersensitivity Syndrome Treatment Market Value (US$ Mn) Forecast, by Drug Class, 2017–2027

Table 13: Asia Pacific Cough Hypersensitivity Syndrome Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

Table 14: Latin America Cough Hypersensitivity Syndrome Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 15: Latin America Cough Hypersensitivity Syndrome Treatment Market Value (US$ Mn) Forecast, by Drug Class, 2017–2027

Table 16: Latin America Cough Hypersensitivity Syndrome Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

Table 17: Middle East & Africa Cough Hypersensitivity Syndrome Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 18: Middle East & Africa Cough Hypersensitivity Syndrome Treatment Market Value (US$ Mn) Forecast, by Drug Class, 2017–2027

Table 19: Middle East & Africa Cough Hypersensitivity Syndrome Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027